IP Verse
Top Law Firms
Unified Patent Court
Trending Technologies
Blogs
Contact Us
Toggle menu
Mitsubishi Pharma Corporation opposition analysis
COMPANY ANALYSIS
Latest patents of Mitsubishi Pharma Corporation opposed by its competitors
Patent:
EP1714960
Grant Date:
Mar 28, 2018
Title:
Novel Therapeutic Agent For Amyotrophic Lateral Sclerosis (Als) Or Disease Attributable To Als
Oppositions:
1
Latest patents of Mitsubishi Pharma Corporation opposed by its competitors
Patent Number
Grant Date
Title
Total Oppositions
EP1714960
Mar 28, 2018
Novel Therapeutic Agent For Amyotrophic Lateral Sclerosis (Als) Or Disease Attributable To Als
1
Competitors of Mitsubishi Pharma Corporation
MAIWALD GMBH
Want to track Mitsubishi Pharma Corporation?
Feel free to send us a message here and we will get back to you
Name
Email
Message
Let's get in touch